Table 1. Correlation between expression of PGC-1α /ERRα and clinicopathologic features.
PGC-1α | ERRα | |||||||
+ | ++ | +++ | P | + | ++ | +++ | P | |
All case | 41 | 66 | 14 | 45 | 64 | 10 | ||
Normal endometrium | 18 | 22 | 0 | 29 | 9 | 0 | ||
Cancers | 23 | 44 | 14 | 16 | 55 | 10 | ||
FIGO stage | ||||||||
I | 17 | 25 | 9 | 0.793 | 13 | 31 | 7 | 0.407 |
II | 1 | 9 | 3 | 1 | 11 | 1 | ||
III-IV | 5 | 10 | 2 | 2 | 13 | 2 | ||
Grade | ||||||||
I | 7 | 19 | 6 | 0.181 | 5 | 22 | 5 | 0.121 |
II | 11 | 15 | 5 | 9 | 18 | 4 | ||
III | 2 | 3 | 0 | 2 | 3 | 0 | ||
Histology | ||||||||
Endometrioid adenocarcinoma | 18 | 36 | 11 | 0.928 | 15 | 41 | 9 | 0.127 |
Non- adenocarcinoma | 5 | 8 | 3 | 1 | 14 | 1 | ||
Myometrial invasion | ||||||||
<1/2 | 19 | 30 | 7 | 0.038* | 15 | 35 | 6 | 0.039* |
≥1/2 | 4 | 14 | 7 | 1 | 20 | 4 | ||
Nodal metastasis | ||||||||
Negative | 19 | 39 | 13 | 0.549 | 14 | 49 | 8 | 0.985 |
Positive | 4 | 4 | 1 | 2 | 6 | 1 |
Data between different groups were compared using χ2 tests. *mean P<0.05